Frédérique Nowak, 2025 France Genomic Medicine Initiative, France

Frédérique Nowak is the coordinator of the 2025 French Genomic Medicine Initiative (Plan France Médecine Génomique 2025 – PFMG2025), that aims to implement precision medicine into the national healthcare system in France, with the ambition to be within a continuum between care and research.

After a master in bioengineering from the Ecole Centrale of Paris, Frédérique Nowak started her career at the Institut Gustave Roussy, Villejuif, France, where she got a PhD in Molecular Pharmacology. After her PhD, she joined Genset, a biotechnology company, where she has been project manager for innovative projects in high-throughput molecular cytogenetics. Between 2002 and 2006, she was responsible for a R&D team at the Serono Genetics Institute of the Serono pharmaceutical company in Evry, France. In 2006, she joined the French National Cancer Institute (Institut National du Cancer – INCa), the health and science agency in charge of cancer control in France, where she was the Head of the Biology, Technology Transfer and Innovations Department. She was in charge of the coordination of the INCa’s precision oncology programs and more particularly of the nationwide initiative for providing an equal access to molecular testing. In 2019, she joined Inserm to be the deputy coordinator of the 2025 French Genomic Medicine Initiative, before becoming its coordinator in 2021.

Read more